Skip to main content

Table 2 Univariate logistic regression analysis of retinal detachment and non-retinal detachment

From: Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab

Factors

Retinal detachment N = 35

Non-retinal detachment N = 125

OR

95% CI

P value

GA (weeks)

30.7 ± 2.0

29.8 ± 2.0

1.249

1.037,1.505

0.019

BW (g)

1376 ± 374

1330 ± 323

1.000

0.999,1.002

0.472

PMA (weeks)

38.3 ± 2.0

36.2 ± 1.8

1.905

1.456,2.491

< 0.01

Gender (male/female)

18/9

50/21

1.526

0.702,3.317

0.286

Neutrophil count (*109/L)

1.95 ± 1.08

2.66 ± 1.60

0.68

0.494,0.938

0.019

Lymphocyte count (*109/L)

4.91 ± 1.39

4.84 ± 1.53

1.034

0.806,1.326

0.794

NLR, median (QAR)

0.37 (0.19,0.60)

0.49 (0.33,0.75)

0.322

0.091,1.137

0.078

INV, n (%)

9 (25.7)

43 (34.4)

0.66

0.284,1.534

0.334

Retinal hemorrhage, n (%)

17 (48.6)

43 (34.4)

1.801

0.843,3.846

0.129

NRDS (treated with mechanical ventilation and surfactant) n (%)

2 (5.7)

11 (8.8)

1.173

0.945,1.456

0.149

Retreatment methods

 NO, n (%)

15 (42.9)

43 (34.4)

  

0.423

 IVR, n (%)

12 (34.2)

35 (28.0)

1.570

0.458,5.384

0.473

 Laser, n (%)

4 (11.4)

29 (23.2)

1.543

0.435,5.474

0.502